Duke University

FDA study finds little harm in 'distracting visuals'

FDA study finds little harm in 'distracting visuals'

By

An FDA study on the power of background visuals found no evidence that consumer understanding of risk info is affected by the "emotional (affective) tone of images."

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters